ArticleBMC infectious diseases2025
Prevalence of protozoa in HIV/AIDS patients with Gastrointestinal symptoms in Zinder National Hospital, Niger Republic.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- PPAR-γ participates in macrophage polarization induced by Pentatrichomonas hominis.Medical microbiology and immunology · 2026Article
- Mixed intestinal protozoal infection masquerading as ulcerative colitis in advanced AIDS: a case report.Frontiers in medicine · 2026Article
- Prevalence, Genetic Diversity, and Risk Factors ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntestinal parasitic infections constitute one of the stubborn public health issues, particularly in low- and middle-income countries. This study aimed to investigate the prevalence and diversity of intestinal parasites and protozoa among HIV/AIDS patients in a medical center in Zinder, Niger Republic.
methodsA total of 224 HIV-immunocompromised patients were hospitalized for acute febrile gastroenteritis. This was a prospective and retrospective descriptive study. A first prospective phase involved 93 patients and a second retrospective phase 131 patients. Stool samples were examined for parasites using standard microscopic techniques.
resultsIn this prospective study, 83.7% of stool samples were tested positive for parasites and protozoa, with the cystic form of Entamoeba histolytica/dispar/moskovskii cysts (25.8%) and Cryptosporidium spp. (30.1%) being the most prevalent. Four patients had trophozoite of protozoa, including two with Giardia intestinalis (2.1%) and two with Entamoeba histolytica/dispar/moskovskii cysts (2.1%), and one patient was positive for Strongyloides stercoralis. In the retrospective study, 46.9% of stool samples were positive for parasites, with the Entamoeba histolytica/dispar/moskovskii cysts and Pentatrichomonas hominis being the most prevalent 26.1% and 7.1%, respectively. Trophozoite of Entamoeba histolytica/dispar/moskovskii cysts and G. intestinalis were present respectively in 3.2% and 2.8% of positive samples as well. Oocysts of two protozoans were identified. Cryptosporidium spp., is characterized by 28 oocysts, constituted 30.1% of the observed entities. Simultaneously, Cystoisospora belli, represented by 12 oocysts, accounted for 12.9% of the total examined samples.
conclusionOur findings reveal a high prevalence of intestinal protozoan parasites in HIV/AIDS patients in Niger. This point at the need for effective interventions to prevent and treat these infections. In addition, the results of this study provide important preliminary data that could inform public health policy and decision makers in the region. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.